Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 20 of 22
-
Citation: Cancer Imaging 2014 14(Suppl 1):O46
-
Incidental lesion in oncology patients: kidneys
Citation: Cancer Imaging 2014 14(Suppl 1):O44 -
Incidental findings in the oncology patient: liver
Citation: Cancer Imaging 2014 14(Suppl 1):O42 -
Role of dual phase MDCT in renal cancer – beyond the renal mass
Citation: Cancer Imaging 2014 14(Suppl 1):P41 -
Batson’s plexus and retrograde venous spread of malignancy – a pictorial review
Citation: Cancer Imaging 2014 14(Suppl 1):P40 -
Optimising structural imaging of neuroendocrine tumours in the molecular imaging age
Citation: Cancer Imaging 2014 14(Suppl 1):P38 -
Imaging manifestations of unusual side effects of new anticancer medications
Citation: Cancer Imaging 2014 14(Suppl 1):P37 -
Pictorial review of cardiac sarcomas and their mimickers
Citation: Cancer Imaging 2014 14(Suppl 1):P36 -
Evaluation of hepatic flow changes in early stages after extended hepatectomy by contrast enhanced ultrasound
Citation: Cancer Imaging 2014 14(Suppl 1):P35 -
PET / MR as tool for ”precision medicine”
Citation: Cancer Imaging 2014 14(Suppl 1):O34 -
Alteration of MR-DWI/ADC before and 24h after induction of chemotherapy in patients with lung cancer
Citation: Cancer Imaging 2014 14(Suppl 1):P34 -
Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a comparative multimodality imaging study
Citation: Cancer Imaging 2014 14(Suppl 1):P33 -
Image directed lymph node sampling for lung cancer staging
Citation: Cancer Imaging 2014 14(Suppl 1):P32 -
Whole-body MRI and diffusion MRI
Citation: Cancer Imaging 2014 14(Suppl 1):O31 -
Imaging diagnostic standard in multiple endocrine neoplasia (MEN)
Citation: Cancer Imaging 2014 14(Suppl 1):P31 -
Value of FDG PET/CT in the assessment of patients with colon cancer comparing to stand-alone CT
Citation: Cancer Imaging 2014 14(Suppl 1):P29 -
Interest of reference region models to monitor cancer treatment using dynamic contrast enhanced studies
Citation: Cancer Imaging 2014 14(Suppl 1):P28 -
CTPA for clinically suspected pulmonary emboli in oncology patients
Citation: Cancer Imaging 2014 14(Suppl 1):P27 -
Acute presentation of oncologic disease
Citation: Cancer Imaging 2014 14(Suppl 1):P25 -
FDG-PET in lymphoma
Citation: Cancer Imaging 2014 14(Suppl 1):O23 -
Use of textural analysis of tumour vascular heterogeneity as a biomarker of response to anti-angiogenic treatment in patients with nasopharyngeal carcinoma
Citation: Cancer Imaging 2014 14(Suppl 1):P23 -
Incremental diagnostic value of 18F-FDG PET/CT in the work up of adult limb and body wall sarcomas. A single centre experience
Citation: Cancer Imaging 2014 14(Suppl 1):P21 -
Metastasis: imaging shows the way
Citation: Cancer Imaging 2014 14(Suppl 1):O19 -
The impact of radiologists’ expertise on screen result decisions in CT lung cancer screening
Citation: Cancer Imaging 2014 14(Suppl 1):P19 -
ICIS workshop on adnexal mass characterization
Citation: Cancer Imaging 2014 14(Suppl 1):O17 -
Dual-energy CT for therapy monitoring: histogram analyses of iodine maps reveal typical pattern of enhancement
Citation: Cancer Imaging 2014 14(Suppl 1):P17 -
Evaluation of hepatic lesions in 30 proven cases of MEN-syndrome
Citation: Cancer Imaging 2014 14(Suppl 1):P15 -
Prospects and challenges of US and CEUS
Citation: Cancer Imaging 2014 14(Suppl 1):O13 -
Quantitative magnetic resonance imaging of microvascular changes in KHT sarcoma
Citation: Cancer Imaging 2014 14(Suppl 1):P13 -
Diagnostic accuracy of Staging of Wilms’ Tumour in the era of multislice CT
Citation: Cancer Imaging 2014 14(Suppl 1):S12 -
Impact of three dimensional tomosynthesis on the detection and diagnosis of breast lesions
Citation: Cancer Imaging 2014 14(Suppl 1):P11 -
Staging the clinically negative neck in T1-T2 oral cancers: USgFNAC and sentinel node biopsy
Citation: Cancer Imaging 2014 14(Suppl 1):S10 -
Whole-body diffusion-weighted imaging for staging lymphoma: are apparent diffusion coefficient derived histogram parameters useful for lesion characterisation?
Citation: Cancer Imaging 2014 14(Suppl 1):S9 -
Diagnostic accuracy of MRI in local staging of rectal cancer, and determining the surgical resection margin status; retrospective study. The experience in Oman
Citation: Cancer Imaging 2014 14(Suppl 1):P9 -
MRI for managing intermediate & low risk prostate cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O9 -
Patient outcome after pulmonary radiofrequency ablation: a prospective analysis of results from a single centre
Citation: Cancer Imaging 2014 14(Suppl 1):P8 -
Three-dimensionally fused gadolinium-enhanced and diffusion-weighted images: value in determination of multi-centricity of breast carcinoma
Citation: Cancer Imaging 2014 14(Suppl 1):S8 -
Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma
Citation: Cancer Imaging 2014 14(Suppl 1):S7 -
Pictorial review of appearances post lung thermal ablation: what is normal?
Citation: Cancer Imaging 2014 14(Suppl 1):P7 -
What is the importance of solitary focal bony FDG-uptake on 18F-FDG PET-CT of known cancer patients?
Citation: Cancer Imaging 2014 14(Suppl 1):P6 -
CT texture analysis of pulmonary lesions in patients suspected for lung cancer
Citation: Cancer Imaging 2014 14(Suppl 1):S6 -
Robot-assisted navigation system for CT-guided percutaneous lung tumour procedures: our initial experience in Hong Kong
Citation: Cancer Imaging 2014 14(Suppl 1):S5 -
Incidence of sarcoid-like reaction demonstrated on 18F-FDG PET-CT in head and neck cancer patients
Citation: Cancer Imaging 2014 14(Suppl 1):P5 -
Prevalence of malignancy in patients with fever of unknown origin (FUO) demonstrated in 18F-FDG PET-CT – prospective multi-centre study
Citation: Cancer Imaging 2014 14(Suppl 1):P4 -
Biliary tract neoplasms: detection and staging CT and Ultrasound
Citation: Cancer Imaging 2014 14(Suppl 1):O4 -
Localised prostate cancer treated with MRI-guided transurethral ultrasound ablation: phase I trial results
Citation: Cancer Imaging 2014 14(Suppl 1):S3 -
Prevalence of osteoradionecrosis demonstrated in 18F-FDG PET-CT of post-high-dose-radiotherapy head and neck cancer patients
Citation: Cancer Imaging 2014 14(Suppl 1):P3 -
Can we save our resources with half-body-18F-FDG-PET-CT rather than whole-body, in the management of head & neck cancers?
Citation: Cancer Imaging 2014 14(Suppl 1):P2 -
Challenges of cancer imaging in Africa
Citation: Cancer Imaging 2014 14(Suppl 1):O2 -
Therapy response assessment with quantitative PET: evaluation of a shortened acquisition protocol with dynamic PET/CT
Citation: Cancer Imaging 2014 14(Suppl 1):S1
Official journal of
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.5
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.416
SCImago Journal Rank (SJR): 1.227Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 157Usage 2024
Downloads: 976,377
Altmetric mentions: 193